REMEDI Expands from India’s Central Government to State Governments, Targeting Additional Orders for Handheld X-ray Machines

[Financial News]  REMEDI, a medical imaging company specializing in handheld X-ray machines, is targeting the tuberculosis screening market operated by state governments and local communities, building on its supply track record with India’s central government. Beyond simply exporting equipment, the key is to secure additional orders as India’s tuberculosis screening network expands from the central government to local areas.
According to REMEDI on the 22nd, the company held the Korea-India Healthcare Cooperation Symposium (Symposium Korea-India Healthcare Cooperation) in New Delhi on the 16th to discuss tuberculosis diagnostic technology and ways to expand field screening.
The event was attended by representatives from the Embassy of the Republic of Korea in India, Indian health authorities and tuberculosis-related organizations, the Tuberculosis Association of India, and the Philippine Tuberculosis Association. Expanding early diagnosis and community-based screening was a key agenda item, as India seeks to achieve its goal of eliminating tuberculosis by 2030.
REMEDI is focusing on changes in tuberculosis screening methods. As active screening expands beyond diagnosing patients after they visit medical institutions to reaching high-risk groups and areas with limited access to healthcare, the use of handheld X-ray machines could grow because they are easy to transport and install. Combining them with artificial intelligence (AI)-based image analysis could also improve the efficiency of screening in areas that lack specialized medical personnel.
REMEDI has already gained experience supplying and installing equipment through projects related to India’s central government. The company plans to use this as a local track record and expand its supply channels to state governments, local health authorities, community-based programs, and mobile screening projects.
The medical industry also sees the future growth of India’s tuberculosis screening market coming from follow-up demand at the state and local levels, rather than from one-time orders by the central government. An industry official said, "Securing a supply track record through a central government project can provide an advantage when entering state government or local screening programs. As mobile screening becomes more widespread, the possibility of repeat orders for handheld X-ray machines will also increase."
India has more than 1.4 billion people and carries the world’s largest tuberculosis burden. REMEDI believes that if the central government-led tuberculosis response expands into local-level screening, additional demand for handheld X-ray machines could emerge, particularly in populous states and areas with a high tuberculosis burden.
A REMEDI representative emphasized, "The rollout of handheld X-ray machines in India is in the early stages of expanding the tuberculosis screening market. Having secured local supply experience and a track record, we will focus on turning the expansion of state and local programs into additional orders."


[email protected] Kim Kyung-ah Reporter